BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16642533)

  • 1. Synthesis and structural model of an alpha(2,6)-sialyl-t glycosylated MUC1 eicosapeptide under physiological conditions.
    Dziadek S; Griesinger C; Kunz H; Reinscheid UM
    Chemistry; 2006 Jun; 12(19):4981-93. PubMed ID: 16642533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein.
    Kirnarsky L; Prakash O; Vogen SM; Nomoto M; Hollingsworth MA; Sherman S
    Biochemistry; 2000 Oct; 39(39):12076-82. PubMed ID: 11009623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
    Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
    Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
    Dziadek S; Brocke C; Kunz H
    Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.
    Schuman J; Campbell AP; Koganty RR; Longenecker BM
    J Pept Res; 2003 Mar; 61(3):91-108. PubMed ID: 12558945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
    Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
    Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic glycopeptides for the development of tumour-selective vaccines.
    Kunz H
    J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains.
    Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S
    Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
    Matsushita T; Ohyabu N; Fujitani N; Naruchi K; Shimizu H; Hinou H; Nishimura S
    Biochemistry; 2013 Jan; 52(2):402-14. PubMed ID: 23259747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
    Soares M; Hanisch FG; Finn OJ; Ciborowski P
    Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational consequences of protein glycosylation: preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from alpha-dystroglycan.
    Liu M; Borgert A; Barany G; Live D
    Biopolymers; 2008; 90(3):358-68. PubMed ID: 17868094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses.
    von Mensdorff-Pouilly S; Kinarsky L; Engelmann K; Baldus SE; Verheijen RH; Hollingsworth MA; Pisarev V; Sherman S; Hanisch FG
    Glycobiology; 2005 Aug; 15(8):735-46. PubMed ID: 15814824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of peptide substrates for mucin-type O-glycosylation.
    Kirnarsky L; Nomoto M; Ikematsu Y; Hassan H; Bennett EP; Cerny RL; Clausen H; Hollingsworth MA; Sherman S
    Biochemistry; 1998 Sep; 37(37):12811-7. PubMed ID: 9737858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.